You have access
Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept
YUNAMI YAMADA, NOBUHISA MATSUHASHI, HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, TAKAO TAKAHASHI, DAICHI WATANABE, SHIGERU KIYAMA, RYO KOBAYASHI, AKIO SUZUKI and KAZUHIRO YOSHIDA
Anticancer Research January 2021, 41 (1) 533-541; DOI: https://doi.org/10.21873/anticanres.14805